In a mouse model of type 2 diabetes, SPX treatment has been shown to reduce inflammation by decreasing tumor necrosis factor-alpha and interleukin-6 levels in both serum and liver tissues17. The gene discussed is IL6; the disease is type 2 diabetes mellitus.